Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice

Oncogene

Volumn 16, Issue 24, 1998, Pages 3097-3104

  Bugge, Thomas H ^a   Lund, Leif R ^b   Kombrinck, Keith K ^a   Nielsen, Boye S ^b   Holmbäck, Kenn ^a   Drew, Angela F ^a   Flick, Matthew J ^a   Witte, David P ^a   Danø, Keld ^b   Degen, Jay L ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b FINSEN LABORATORY   (Denmark)

Author keywords

Cancer; Gene targeting; Mammary carcinoma; Metastasis; Plasminogen

Indexed keywords

PLASMIN; PLASMINOGEN; VIRUS MIDDLE T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; FEMALE; LONG TERMINAL REPEAT; LUNG METASTASIS; METASTASIS POTENTIAL; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALIA; MAMMARY TUMOR ONCOVIRUS; MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS; ONCOVIRINAE; POLYOMAVIRUS; TUMOR VIRUS;

EID: 7344248988     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201869     Document Type: Article

References (80)

1. Anderson IC, Shipp MA, Docherty AJP and Teicher BA. (1996). Cancer Res., 56, 715-718.
2. Belin D, Vasalli J-D, Combepine C, Godeau F, Nagamine Y, Reich E, Kocher HP and Duvoisin RM. (1985). Eur. J. Biochem., 148, 225-232.
3. Brown LF, Asch B, Harvey VS, Buchinski B and Dvorak HF. (1988). Cancer Res., 48, 1920-1925.
4. Brunner G, Gabrilove J, Rifkin DB and Wilson EL. (1991). J. Cell Biol., 6, 1275-1283.
5. Bugge TH, Flick MJ, Daugherty CC and Degen JL. (1995). Genes & Dev., 9, 794-807.
6. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJS and Degen JL. (1996). Cell, 87, 709-719.
7. Bugge TH, Kombrinck KW, Xiao Q, Holmbäck K, Daugherty CC, Witte DP and Degen JL. (1997). Blood, 90, 4522-4531.
8. Carmeliet P, Schoojans L, Kieckens L, Ream B, Degen JL, Bronson R, DeVos R, van den Oord JJ, Collen D and Mulligan RC. (1994). Nature, 368, 419-424.
9. Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH and Benach JL. (1997). Cell, 89, 1111-1119.
10. Collen D and Lijnen HR. (1994). In: Stamatoyannopoulos GS, Nienhuis AW, Majerus PW, Varmus H (eds.) The Molecular Basis of Blood Diseases. WB Saunders Co: Philadelphia, PA, pp. 725-752.
11. Conway JG, Trexler SJ, Wakefield JA, Marron BE, Emerson DL, Bickett DM, Deaton DN, Garrison D, Elder M, McElroy A, Willmott N, Dockerty AJ and McGeehan GM. (1996). Clin. Exp. Metastasis, 14, 115-124.
12. Crawford HC and Matrisian LM. (1995). Invasion and Metastasis, 14, 234-245.
13. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA and Levinson AD. (1993). Proc. Natl. Acad. Sci. USA, 90, 5021-5025.
14. Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS and Skriver L. (1985). Adv. Cancer. Res. 44, 139-266.
15. Danø K, Behrendt N, Brünner N, Ellis V, Ploug M and Pyke C. (1994). Fibrinolysis, 9, 189-203.
16. Drew AF, Kaufman A, Kombrinck KW, Daugherty CC, Danton MJS, Degen JL and Bugge TH. (1998). Blood, 91, 1616-1624.
17. Duffy MJ, Reilly D, O'Sullivan C, O'Higgins N, Fennely JJ and Andreassen PA. (1990). Cancer Res., 50, 6827-6829.
18. Duffy MJ. (1992). Clin. Exp. Met., 10, 145-155.
19. Dvorak HF. (1986). N. Eng. J. Med., 315, 1650-1659.
20. Dvorak HF, Nagy JA, Berse B, Brown LF, Yeo K-T, Yeo T-K, Dvorak AM, Van De Water L, Siousat TM and Senger DR. (1992). Ann. NY Acad. Sci., 667, 101-111.
21. Foekens JA, Schmitt M, Van Putten WLJ, Peters HA, Bontenbal M, Janicke F and Klijn JGM. (1992). Cancer Res., 52:6101-6105.
22. Fraki JE, Lazarus GS, Gilgor RS, Marchase P and Sinner KH. (1983). Br. J. Dermatol., 108, 39-44.
23. Ganesh S, Siene CEM, Heerding MM, Griffioen G, Lamers CBHW and Verspaget HW. (1994). Cancer Res., 54, 4065-4071.
24. Grødahl-Hansen J, Christensen IJ, Rosenquist C, Brünner N, Mouridsen HT, Danø K and Bliehert-Toft M. (1993). Cancer Res., 53, 2513-2521.
25. Guy CT, Cardiff RD and Muller WJ. (1992). Mol. Cell. Biol., 12, 954-961.
26. Harris NL, Dvorak AM, Smith J and Dvorak HF. (1982). Amer. J. Pathol., 108, 119-129.
27. Hearing VJ, Law LW, Corti A, Apella E and Blasi F. (1988). Cancer Res., 48, 1270-1278.
28. Meinert G, Kircheimer JC, Ptluger H and Binder H. (1988). J. Urol., 140, 1466-1469.
29. Heiss MM, Allgayer H, Cruetznier KU, Funke I, Babic R, Jauch KW and Schildberg FW. (1995). Nature Medicine, 1, 1035-1039.
30. Holmbäek K, Danton MJS, Suh TT, Daugherty CC and Degen JL. (1996). EMBO J., 15, 5760-5771.
31. Janicke F, Schmitt M, Ulm K, Gossner W and Gnief H. (1989). Lancet, 2, 1049.
32. Kobayashi H, Gotoh J, Shinohara H, Moniwa N and Terao T. (1994a). Thromb. Haemostasis. 71, 474-480.
33. Kobayashi H, Gotoh J, Fujie M, Shinohara H, Moniwa N and Terao T. (1994b). Int. J. Cancer, 57, 727-733.
34. Kohn EC and Liotta LA. (1995). Cancer Res. 55, 1856 1862.
35. Kook YH, Adamski J, Zelent A and Ossowski L. (1994). EMBO J., 13, 3983-3991.
36. Kristensen P, Eriksen J and Danø K. (1991). J. Histochem. Cytochem., 39, 341-349.
37. Liotta LA and Steeg PS. (1991). Cell, 64, 327-336.
38. Martin DC, Rüther U, Sanchez-Sweatman OH, Orr FW and Khoka R. (1996). Oncogene, 13, 569-576.
39. Min YM, Doyle LV, Vitt CR, Zandonella CL, Stratton-Thomas JR, Shuman MA and Rosenberg S. (1996). Cancer Res., 56, 2428-2433.
40. Mochan E and Uhl J. (1984). J. Rheumatol., 11, 123-128.
41. Mulcahy HE, Duffy MJ, Gibbons D, McCarthy P, Parfrey NA. O'Donoghue DP and Sheahan K. (1994). Lancet, 344, 583-584.
42. Mueller BM, Yu YB and Laug WE. (1995). Proc. Natl. Acad. Sci. USA. 92, 205-209.
43. Nagy JA, Meyers MS, Masse EM, Herzberg KT and Dvorak HF. (1995a). Cancer Res., 55, 369-375.
44. Nagy JA, Morgan ES, Herzberg KT, Manseau EJ, Dvorak AM and Dvorak HF. (1995b). Cancer Res., 55, 376-385.
45. Nekarda H, Siewert JR, Schmitt M and Ulm K. (1994). Lancet, 343, 117.
46. Nielsen BS, Sehested M, Timshel S, Pyke C and Danø K. (1996). Lab. Invest., 74, 168-177.
47. Odekon LE, Blasi F and Rifkin DB. (1994). J. Cell Physiol., 158, 398-407.
48. Oka T, Ishida T, Nishino T and Sugimachi K. (1991). Cancer Res., 51, 3522-3525.
49. Ossowski L and Reich E. (1983). Cell, 35, 611-619.
50. Ossowski L. (1988). Cell, 52, 321-328.
51. Ossowski L, Russo-Payne H and Wilson EL. (1991). Cancer Res., 51, 274-281.
52. Pedersen H, Grøndahl-Hansen J, Francis D, Østerlind K, Hansen HH, Danø K and Brünner N. (1994). Cancer Res., 54, 4671-4675.
53. Ploplis VA, Carmeliet P, Vazirzudeh S, van Vlaenderen I, Moons L, Plow EF and Collen D. (1995). Circulation Res., 92, 2585-2593.
54. Prendergast GC, Diamond LE, Dahl D and Cole MD. (1990). Mol. Cell. Biol., 10, 1265-1269.
55. Pyke C, Kristensen P, Ralfkiaer E, Grondahl-Hansen J. Eriksen J, Blasi F and Danø K. (1991a). Amer. J. Pathol., 138, 1059-1067.
56. Pyke C, Kristensen P, Ralfkiaer E, Eriksen J and Danø K. (1991b). Cancer Res., 51, 4067-4071.
57. Pyke C, Graem N, Ralfkier W, Ronne E, Hoyer-Hansen G, Brünner N and Danø K. (1993). Cancer Res., 53, 1911-1915.
58. Rabbani SA, Harakidas P, Davidson DJ, Henkin J and Mazar AP. (1995). Int. J. Cancer, 63, 840-845.
59. Rømer J, Lund LR, Eriksen J, Ralfkiaer E, Zeheb R, Gelehrter TD, Danø K and Kristensen P. (1991). J. Invest. Dermatol., 97, 803-811.
60. Rømer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL and Danø K. (1996). Nature Medicine, 2, 287-292.
61. Saftig P, Hetman M, Sehmahl W, Weher K, Heine L, Mossmann H, Koster A, Hess B, Evers M, von Figura K and Peters C. (1995). EMBO J., 14, 3599-3608.
62. Saksela O and Rifkin, DB. (1988). Aninu. Rev. Cell Biol., 4, 93-126.
63. Salonen EM, Tervo T, Torma E, Tarkkanen A and Vaheri A. (1987). Acta Ophthalmologica, 65, 3-12.
64. Sappino AP, Busso N, Belin D, and Vassalli JD. (1987). Cancer Res., 47, 4043-4046.
65. Schuster V, Mingers A-M, Seidenspinner S, Nüssgens Z, Pukrop T and Kreht HW. (1997). Blood, 90, 958-966.
66. Schwartz MK. (1995). Clinica Chemica Acta, 237, 67-68.
67. Shapiro RL, Duquette JG, Roses DF, Nunes I, Harris MN, Kamino H, Wilson EL and Rifkin DB. (1996). Cancer Res., 56, 3597-3604.
68. Shipley JM, Wesselschmidt RL, Kohayashi DK, Ley TJ and Shapiro SD. (1996). Proc. Natl. Acad. Sci. USA, 93, 3942-3946.
69. Skriver L, Larsson LI, Keilberg V, Nielsen LS and Andreasen PB. (1984). J. Cell Biol., 99, 752-757.
70. Sledge GW, Qulali M, Goulet R, Bone EA and Fife R. (1995). J. Natl. Cancer Inst., 87, 1546-1550.
71. Soeda E, Arrand JR, Smolar N, Walsh JE and Griffin BE. (1980). Nature, 283, 445-453.
72. Stetler-Stevenson WG, Aznavoorian S and Liotta LA. (1993). Annu. Rev. Cell Biol., 9, 541-573.
73. Tsirka SE, Rogove AD, Bugge TH, Degen JL and Strickland S. (1997a). J. Neurosci., 17, 543-552.
74. Tsirka SE, Bugge TH, Degen JL and Strickland S. (1997b). Proc. Natl. Acad. Sci. USA, 94, 9779-9781.
75. Vassali J-D, Wohlwend A, Belin D. (1991). J. Clin. Invest., 88, 1067-1072.
76. Vassali J-D, Sappino A-P and Belin D. (1992). Curr. Top. Microbiol. Immunol., 181, 65-86.
77. Werb Z, Mainardi C, Vater CA and Harris ED. (1977). N. Engl. J. Med., 296, 1017-1023.
78. Wilson CT, Heppner KJ, Labosky PA, Hogan BLM and Matrisian LM. (1997). Proc. Natl. Acad. Sci. USA, 94, 1402-1407.
79. Xiao Q, Danton MJS, Witte DP, Kowala MC, Valentine MT, Bugge TH and Degen JL. (1997). Proc. Natl. Acad. Sci. USA, 94, 10335-10340.
80. Yu H and Schultz RM. (1990). Cancer Res., 50, 7623-7633.